The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Clover Health Investments Corp (NASDAQ: CLOV) closed at $0.69 in the last session, up 7.84% from day before closing price of $0.64. In other words, the price has increased by $7.84 from its previous closing price. On the day, 3.49 million shares were traded. CLOV stock price reached its highest trading level at $0.695 during the session, while it also had its lowest trading level at $0.6534.
Ratios:
We take a closer look at CLOV’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Cowen on February 02, 2022, Upgraded its rating to Market Perform and sets its target price to $3 from $7 previously.
On February 02, 2022, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $6.
On January 19, 2022, SVB Leerink started tracking the stock assigning a Mkt Perform rating and target price of $3.SVB Leerink initiated its Mkt Perform rating on January 19, 2022, with a $3 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 14 ’24 when Loengard Anna U bought 137,000 shares for $0.73 per share. The transaction valued at 100,010 led to the insider holds 538,841 shares of the business.
Loengard Anna U bought 13,625 shares of CLOV for $9,946 on Mar 14 ’24. The Director now owns 15,125 shares after completing the transaction at $0.73 per share. On Sep 06 ’23, another insider, Loengard Anna U, who serves as the Director of the company, bought 11,000 shares for $1.30 each. As a result, the insider paid 14,300 and bolstered with 10,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLOV now has a Market Capitalization of 344580992 and an Enterprise Value of 106206264. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.17 while its Price-to-Book (P/B) ratio in mrq is 1.17. Its current Enterprise Value per Revenue stands at 0.052 whereas that against EBITDA is -0.571.
Stock Price History:
Over the past 52 weeks, CLOV has reached a high of $1.63, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is -8.08%, while the 200-Day Moving Average is calculated to be -29.97%.
Shares Statistics:
According to the various share statistics, CLOV traded on average about 9.28M shares per day over the past 3-months and 3426650 shares per day over the past 10 days. A total of 393.27M shares are outstanding, with a floating share count of 376.56M. Insiders hold about 23.70% of the company’s shares, while institutions hold 19.66% stake in the company. Shares short for CLOV as of 1713139200 were 48155925 with a Short Ratio of 5.19, compared to 1710460800 on 47535889. Therefore, it implies a Short% of Shares Outstanding of 48155925 and a Short% of Float of 12.04.
